|
1
|
Tsunemi T, Nagoya S, Kaya M, Kawaguchi S,
Wada T, Yamashita T and Ishii S: Postoperative progression of
pulmonary metastasis in osteosarcoma. Clin Orthop Relat Res.
159–166. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bacci G, Longhi A, Versari M, Mercuri M,
Briccoli A and Picci P: Prognostic factors for osteosarcoma of the
extremity treated with neoadjuvant chemotherapy: 15-year experience
in 789 patients treated at a single institution. Cancer.
106:1154–1161. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Meyers PA, Gorlick R, Heller G, Casper E,
Lane J, Huvos AG and Healey JH: Intensification of preoperative
chemotherapy for osteogenic sarcoma: results of the Memorial
Sloan-Kettering (T12) protocol. J Clin Oncol. 16:2452–2458.
1998.PubMed/NCBI
|
|
4
|
Bacci G, Briccoli A, Longhi A, Ferrari S,
Mercuri M, Faggioli F, Versari M and Picci P: Treatment and outcome
of recurrent osteosarcoma: Experience at Rizzoli in 235 patients
initially treated with neoadjuvant chemotherapy. Acta Oncol.
44:748–755. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Janeway KA, Barkauskas DA, Krailo MD,
Meyers PA, Schwartz CL, Ebb DH, Seibel NL, Grier HE, Gorlick R and
Marina N: Outcome for adolescent and young adult patients with
osteosarcoma: A report from the children's oncology group. Cancer.
118:4597–4605. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pillai RS: MicroRNA function: Multiple
mechanisms for a tiny RNA? RNA. 11:1753–1761. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zamore PD and Haley B: Ribo-gnome: The big
world of small RNAs. Science. 309:1519–1524. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bentwich I, Avniel A, Karov Y, Aharonov R,
Gilad S, Barad O, Barzilai A, Einat P, Einav U, Meiri E, et al:
Identification of hundreds of conserved and nonconserved human
microRNAs. Nat Genet. 37:766–770. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Berezikov E, Guryev V, van de Belt J,
Wienholds E, Plasterk RH and Cuppen E: Phylogenetic shadowing and
computational identification of human microRNA genes. Cell.
120:21–24. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hwang HW and Mendell JT: MicroRNAs in cell
proliferation, cell death and tumorigenesis. Br J Cancer.
94:776–780. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wienholds E and Plasterk RH: MicroRNA
function in animal development. FEBS Lett. 579:5911–5922. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jovanovic M and Hengartner MO: miRNAs and
apoptosis: RNAs to die for. Oncogene. 25:6176–6187. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sewer A, Paul N, Landgraf P, Aravin A,
Pfeffer S, Brownstein MJ, Tuschl T, van Nimwegen E and Zavolan M:
Identification of clustered microRNAs using an ab initio prediction
method. BMC bioinformatics. 6:2672005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Caporali A, Meloni M, Vollenkle C, Bonci
D, Sala-Newby GB, Addis R, Spinetti G, Losa S, Masson R, Baker AH,
et al: Deregulation of microRNA-503 contributes to diabetes
mellitus-induced impairment of endothelial function and reparative
angiogenesis after limb ischemia. Circulation. 123:282–291. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Landgraf P, Rusu M, Sheridan R, Sewer A,
Iovino N, Aravin A, Pfeffer S, Rice A, Kamphorst AO, Landthaler M,
et al: A mammalian microRNA expression atlas based on small RNA
library sequencing. Cell. 129:1401–1414. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou B, Ma R, Si W, Li S, Xu Y, Tu X and
Wang Q: MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor
angiogenesis and growth. Cancer Lett. 333:159–169. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou J and Wang W: Analysis of microRNA
expression profiling identifies microRNA-503 regulates metastatic
function in hepa-tocellular cancer cell. J Surg Oncol. 104:278–283.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xu YY, Wu HJ, Ma HD, Xu LP, Huo Y and Yin
LR: MicroRNA-503 suppresses proliferation and cell-cycle
progression of endometrioid endometrial cancer by negatively
regulating cyclin D1. FEBS J. 280:3768–3779. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Peng Y, Liu YM, Li LC, Wang LL and Wu XL:
microRNA-503 inhibits gastric cancer cell growth and
epithelial-to-mesenchymal transition. Oncol Lett. 7:1233–1238.
2014.PubMed/NCBI
|
|
22
|
Sarver AL, Li L and Subramanian S:
MicroRNA miR-183 functions as an oncogene by targeting the
transcription factor EGR1 and promoting tumor cell migration.
Cancer Res. 70:9570–9580. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gong C, Yao Y, Wang Y, Liu B, Wu W, Chen
J, Su F, Yao H and Song E: Up-regulation of miR-21 mediates
resistance to trastuzumab therapy for breast cancer. J Biol Chem.
286:19127–19137. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Suh SS, Yoo JY, Nuovo GJ, Jeon YJ, Kim S,
Lee TJ, Kim T, Bakàcs A, Alder H, Kaur B, et al: MicroRNAs/TP53
feedback circuitry in glioblastoma multiforme. Proc Natl Acad Sci
USA. 109:5316–5321. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhao JJ, Yang J, Lin J, Yao N, Zhu Y,
Zheng J, Xu J, Cheng JQ, Lin JY and Ma X: Identification of miRNAs
associated with tumorigenesis of retinoblastoma by miRNA microarray
analysis. Childs Nerv Syst. 25:13–20. 2009. View Article : Google Scholar
|
|
26
|
Corbetta S, Vaira V, Guarnieri V,
Scillitani A, Eller-Vainicher C, Ferrero S, Vicentini L, Chiodini
I, Bisceglia M, Beck-Peccoz P, et al: Differential expression of
microRNAs in human parathyroid carcinomas compared with normal
parathyroid tissue. Endocr Relat Cancer. 17:135–146. 2010.
View Article : Google Scholar
|
|
27
|
Ozata DM, Caramuta S, Velazquez-Fernandez
D, Akçakaya P, Xie H, Höög A, Zedenius J, Bäckdahl M, Larsson C and
Lui WO: The role of microRNA deregulation in the pathogenesis of
adre-nocortical carcinoma. Endocr Relat Cancer. 18:643–655. 2011.
View Article : Google Scholar
|
|
28
|
Forrest AR, Kanamori-Katayama M, Tomaru Y,
Lassmann T, Ninomiya N, Takahashi Y, de Hoon MJ, Kubosaki A, Kaiho
A, Suzuki M, et al: Induction of microRNAs, mir-155, mir-222,
mir-424 and mir-503, promotes monocytic differentiation through
combinatorial regulation. Leukemia. 24:460–466. 2010. View Article : Google Scholar
|
|
29
|
Sarkar S, Dey BK and Dutta A: MiR-322/424
and -503 are induced during muscle differentiation and promote cell
cycle quiescence and differentiation by down-regulation of Cdc25A.
Mol Biol Cell. 21:2138–2149. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lu YC, Chen YJ, Wang HM, Tsai CY, Chen WH,
Huang YC, Fan KH, Tsai CN, Huang SF, Kang CJ, et al: Oncogenic
function and early detection potential of miRNA-10b in oral cancer
as identified by microRNA profiling. Cancer Prev Res (Phila).
5:665–674. 2012. View Article : Google Scholar
|
|
31
|
Watahiki A and Wang Y, Morris J, Dennis K,
O'Dwyer HM, Gleave M, Gout PW and Wang Y: MicroRNAs associated with
metastatic prostate cancer. PloS One. 6:e249502011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jiang Q, Feng MG and Mo YY: Systematic
validation of predicted microRNAs for cyclin D1. BMC Cancer.
9:1942009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cross MJ and Claesson-Welsh L: FGF and
VEGF function in angiogenesis: signalling pathways, biological
responses and therapeutic inhibition. Trends Pharmacol Sci.
22:201–207. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Carmeliet P and Jain RK: Molecular
mechanisms and clinical applications of angiogenesis. Nature.
473:298–307. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kim J, Kang Y, Kojima Y, Lighthouse JK, Hu
X, Aldred MA, McLean DL, Park H, Comhair SA, Greif DM, et al: An
endothelial apelin-FGF link mediated by miR-424 and miR-503 is
disrupted in pulmonary arterial hypertension. Nat Med. 19:74–82.
2013. View
Article : Google Scholar :
|
|
36
|
Yin KJ, Olsen K, Hamblin M, Zhang J,
Schwendeman SP and Chen YE: Vascular endothelial cell-specific
microRNA-15a inhibits angiogenesis in hindlimb ischemia. J Biol
Chem. 287:27055–27064. 2012. View Article : Google Scholar : PubMed/NCBI
|
